Basis: FMP quote market capitalization / book value attributable to common shareholders (matching reported total stockholders equity minus preferred stock). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the P/B ratio high or low?
The P/B ratio of 0.56 is 11% below its estimated 1-year average of 0.63, near the low end of its estimated 1-year range (0.56–1.00).
As of 2026-10-06T15:36:46.588Z.
Calculation as of: 2026-10-06T15:36:46.588Z.
Quote observation: 2026-10-06T15:28:03.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 6ebeba272bae7de15d59b23151f0025007a9c632b25eeddd13cd9ab927e6ebe5
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PB RATIO
0.56
PB RATIO AVG TTM
N/A
PB RATIO AVG 3Y
N/A
PB RATIO AVG 5Y
N/A
PB RATIO AVG 10Y
N/A
PB RATIO AVG 15Y
N/A
PB RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.38
median of 609 covered companies
CURRENT VS SECTOR MEDIAN
-76.47%
vs the sector median at left
Market Cap
$5.27M
PB Ratio
0.96
TTM Avg
0.99
3Y Avg
1.17
5Y Avg
4.93
Market Cap
$5.16M
PB Ratio
17.18
TTM Avg
6.60
3Y Avg
6.60
5Y Avg
6.60
Market Cap
$5.18M
PB Ratio
1.06
TTM Avg
28.43
3Y Avg
28.43
5Y Avg
28.43
| NAME | MARKET CAP | PB RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Gelteq Limited Ordinary Shares (GELS) | $5.32M | 0.56 | N/A | N/A | N/A |
| Alzamend Neuro Inc (ALZN)vs › | $5.29M | 0.91 | 2.38 | 1.71 | 5.62 |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.27M | 0.96 | 0.99 | 1.17 | 4.93 |
| Pulmatrix, Inc. (PULM)vs › | $5.22M | 3.28 | 2.45 | 1.80 | 1.25 |
| Lunai Bioworks Inc. (LNAI)vs › | $5.19M | N/A | N/A | N/A | N/A |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $5.16M | 17.18 | 6.60 | 6.60 | 6.60 |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.50M | 0.67 | 0.99 | 5.06 | 4.61 |
| Imunon, Inc. (IMNN)vs › | $5.04M | 1.20 | 2.32 | 4.54 | 2.93 |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.18M | 1.06 | 28.43 | 28.43 | 28.43 |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $5.78M | 1.47 | 2.15 | 2.15 | 2.15 |
At 0.56, P/B is below its estimated 1-year median — higher than 0% of readings in its estimated 1-year history.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
estimated 1-year low
0.58
median
0.63
estimated 1-year high
1.00
P/B Ratio
0.56
Market Price / Book Value per Share
PB Ratio = Market Cap / (Total Shareholders' Equity − Preferred Stock)
The price-to-book ratio compares market capitalization to book value attributable to common shareholders (total equity minus preferred stock). Lower values can indicate a cheaper valuation relative to net assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PB RATIO |
|---|---|
| 2026-10-05 | 0.60 |
| 2026-10-02 | 0.58 |
| 2026-10-01 | 0.60 |
| 2026-09-30 | 0.59 |
| 2026-09-29 | 0.59 |
| 2026-09-28 | 0.61 |
| 2026-09-25 | 0.60 |
| 2026-09-24 | 0.61 |
| 2026-09-23 | 0.66 |
| 2026-09-22 | 0.67 |
| 2026-09-21 | 0.63 |
| 2026-09-18 | 0.62 |
| 2026-09-17 | 0.64 |
| 2026-09-16 | 0.64 |
| 2026-09-15 | 0.68 |
| 2026-09-14 | 0.75 |
| 2026-09-11 | 0.77 |
| 2026-09-10 | 0.87 |
| 2026-09-09 | 0.94 |
| 2026-09-08 | 0.75 |
| 2026-09-04 | 1.00 |
| 2026-09-03 | 0.99 |
| 2026-09-02 | 0.77 |
| 2026-09-01 | 0.59 |
| 2026-08-31 | 0.60 |
| 2026-08-28 | 0.61 |
| 2026-08-27 | 0.63 |
| 2026-08-26 | 0.64 |
| 2026-08-25 | 0.61 |
| 2026-08-24 | 0.59 |
| 2026-08-21 | 0.62 |
| 2026-08-20 | 0.62 |
| 2026-08-19 | 0.61 |
| 2026-08-18 | 0.59 |
| 2026-08-17 | 0.62 |
| 2026-08-14 | 0.64 |
| 2026-08-13 | 0.64 |
| 2026-08-12 | 0.63 |
| 2026-08-11 | 0.63 |
| 2026-08-10 | 0.65 |
| 2026-08-07 | 0.62 |
| 2026-08-06 | 0.63 |
| 2026-08-05 | 0.62 |
| 2026-08-04 | 0.59 |
| 2026-08-03 | 0.60 |
| 2026-07-31 | 0.58 |
| 2026-07-30 | 0.61 |
| 2026-07-29 | 0.64 |
| 2026-07-28 | 0.65 |
| 2026-07-27 | 0.73 |
| 2026-07-24 | 0.78 |
| 2026-07-23 | 0.82 |
| 2026-07-22 | 0.75 |
| 2026-07-21 | 0.67 |
| 2026-07-20 | 0.65 |
| 2026-07-17 | 0.67 |
| 2026-07-16 | 0.65 |
| 2026-07-15 | 0.59 |
| 2026-07-14 | 0.59 |
| 2026-07-13 | 0.60 |
| 2026-07-10 | 0.58 |
| 2026-07-09 | 0.60 |
| 2026-07-08 | 0.62 |
| 2026-07-07 | 0.64 |
| 2026-07-06 | 0.66 |
| 2026-07-02 | 0.64 |
| 2026-07-01 | 0.73 |